Team:ETH Zurich/lab/safety

From 2014.igem.org

(Difference between revisions)
Line 54: Line 54:
== Future Risks and risk-reducing features ==
== Future Risks and risk-reducing features ==
-
The way our project is planned we do not intend any industrial, therapeutic, diagnostic or medicinal purposes or applications and so the organisms will be restricted to laboratory environments only. Moreover we see our project as a beginning or foundation and advancement will take time. Therefore it is difficult to envision scenarios where severe dangers are encountered. A possible scenario in the distant future could be that someone modifies our methods and use them with organisms/genes that pose greater risks than the non-pathogenic ''E. coli''.  As the team has only used standard molecular biological methods and protocols that can be conducted in any laboratory fulfilling at least safety level 1 we see no new risks to personal, environmental and public safety arising from our project becoming more popular.
+
The way our project is planned we do not intend any industrial, therapeutic, diagnostic or medicinal purposes or applications and so the organisms will be restricted to laboratory environments only. Moreover we see our project as a beginning or foundation and advancement will take time. Therefore it is difficult to envision scenarios where severe dangers are encountered in the foreseeable future. A possible scenario in the distant future could be that someone modifies our methods and biobricks and usea them with organisms/genes that pose greater risks than the system established here.  As the team has only used standard molecular biological methods and protocols that can be conducted in any laboratory fulfilling at least safety level 1 we see no new risks to personal, environmental and public safety arising from our project becoming more popular.
<br>
<br>
<br>
<br>
-
Our project currently does not include such features. The system is designed in a manner that it will be necessary to have a BSL-1 lab environment that confers to safety measures. In case our project would grow into a popular product we would include a kill-switch in our system to avoid their spreading of the microorganisms outside of the controlled laboratory environment.
+
The system is designed in a manner that it will be necessary to have a BSL-1 lab environment that confers to safety measures. In case our project would grow into a popular product and be used outside of a BSL-1 lab, we would include a kill-switch in our system to avoid their spreading of the microorganisms outside of the controlled laboratory environment.
<html></article></html>
<html></article></html>

Revision as of 12:44, 17 October 2014

iGEM ETH Zurich 2014